Verano Launches “Save the Bits” Fundraising Campaign, Featuring BITS™ Edibles and Industrywide Coalition of Hundreds of Dispensaries Across Eight States, Supporting the Lynn Sage Breast Cancer Foundation
September 24, 2024 06:00 ET
|
Verano Holdings Corp.
Starting October 1, in recognition of Breast Cancer Awareness Month, a portion of every BITS™ edibles purchased at hundreds of dispensaries in eight states will go directly to the Lynn Sage Breast...
Worthington Enterprises Releases 2024 Corporate Citizenship and Sustainability Report
September 23, 2024 08:30 ET
|
Worthington Enterprises, Inc.
Annual Corporate Citizenship and Sustainability Report detailing the Company’s commitments, management approach and achievements within four categories.
Premium Cosmetics Global Analysis Business Report 2024: Market to Reach $196 Billion by 2030 - Focus on Personalized Beauty and Customization Strengthens Business Case
September 20, 2024 09:21 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Premium Cosmetics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Premium...
UAE Cosmetic Pigments Market Trends, Competitive Landscape, Forecast and Opportunities, 2024-2029
September 20, 2024 05:00 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "UAE Cosmetic Pigments Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
ADVANZ PHARMA secures temporary suspension of the European Commission decision on the OCALIVA® conditional marketing authorisation in Europe
September 05, 2024 02:35 ET
|
Advanz Pharma
ADVANZ PHARMA secures temporary suspension of the European Commission decision on the OCALIVA® conditional marketing authorisation in Europe The European Commission’s decision to revoke the OCALIVA®...
ADVANZ PHARMA’s response to European Commission revocation of conditional marketing authorisation for OCALIVA® in rare disease Primary Biliary Cholangitis (PBC)
September 03, 2024 04:00 ET
|
Advanz Pharma
ADVANZ PHARMA’s response to European Commission revocation of conditional marketing authorisation for OCALIVA® in rare disease Primary Biliary Cholangitis (PBC) OCALIVA® is the only farnesoid X...
Ipsen's Iqirvo Shows Strong Start in Primary Biliary Cholangitis, Now Faces Rivalry from Gilead's Livdelzi
August 29, 2024 14:14 ET
|
Spherix Global Insights
EXTON, PA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The past few months have ushered in a new era of treatment for patients suffering from primary biliary cholangitis (PBC), marked by the approval of...
INNOCOS Longevity Summit: Sentosa Island, Singapore - November 6-8, 2024 - Future-proofing Beauty, Health, and Wellness with Data, AI, Trends, Innovations, Scaling, and Investment Opportunities
August 14, 2024 09:12 ET
|
Research and Markets
Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "INNOCOS Longevity Singapore" conference has been added to ResearchAndMarkets.com's offering. At INNOCOS Longevity Summit, they recognise that beauty...
Mountain America Credit Union Awards $300,000 in Elevate Scholarships to 120 Students
June 27, 2024 09:21 ET
|
Mountain America Credit Union
SANDY, Utah, June 27, 2024 (GLOBE NEWSWIRE) -- Mountain America Credit Union, through the Mountain America Foundation, recently awarded 120 students with $2,500 Elevate Scholarships totaling...
Leading Impact Investors and Philanthropists Convene for Mission Investors Exchange 2024 National Conference in Los Angeles in May
April 22, 2024 11:40 ET
|
Mission Investors Exchange
Los Angeles, April 22, 2024 (GLOBE NEWSWIRE) -- The Mission Investors Exchange 2024 National Conference will bring more than 750 philanthropy and impact investing leaders from across the country to...